This post by Erin Sparrow, World Health Organization, has been reposted from the January 2016 issue ofGlobal Immunization News with thanks.
The Global Action Plan for Influenza Vaccines (GAP) was launched in 2006 as a ten year initiative to address the anticipated shortfall in vaccine supply in the event of an influenza pandemic. GAP aims to reduce the global shortage of influenza vaccines for seasonal epidemics and pandemics through three key objectives:
• Objective 1: Increase in the evidence-based use of vaccines to protect against seasonal influenza
• Objective 2: Increase in vaccine production and regulatory capacity
• Objective 3: Research and development in influenza vaccines
A consultation in November 2016 will mark the end of the ten years of GAP. Over these years, much progress has been made in each of the three GAP objectives outlined above, however key gaps also remain. WHO is issuing this questionnaire to solicit feedback on the progress made to date and remaining gaps, which will feed into the development of the agenda for the final GAP consultation.
The questionnaire should take approximately 20 minutes to complete. The majority of the questions included in the survey are general influenza-related questions and can be answered even if you are not familiar with GAP. The survey will close on 29 February 2016. All responses will be treated in confidence and aggregated in anonymized formats.